Recombinant Human Probable G-protein coupled receptor 153 (GPR153)

What is GPR153 and which protein family does it belong to?

GPR153 is an orphan G-protein coupled receptor that belongs to the Rhodopsin family of GPCRs. Specifically, phylogenetic analyses have placed GPR153 in the α-group of the Rhodopsin family . This is particularly significant because the α-group is the only GPCR group that contains numerous receptors for biogenic amines, which represent major drug targets in pharmaceutical research . The human GPR153 is encoded by the GPR153 gene located at chromosome 1p36.31 and produces a protein with a molecular mass of 65,361 Da . The receptor consists of 609 amino acids and contains the characteristic seven transmembrane domains typical of GPCRs .

How evolutionarily conserved is GPR153?

GPR153 demonstrates significant evolutionary conservation across multiple species. The GPR153 gene has been identified in chimpanzees, Rhesus monkeys, dogs, cows, mice, rats, chickens, frogs, and zebrafish, indicating strong conservation throughout vertebrate evolution . Phylogenetic and synteny analyses have revealed that GPR153 and GPR162 share a common ancestral gene that likely underwent a duplication event prior to the divergence of tetrapods and the teleost lineage . Researchers have identified GPR153 homologues in the elephant shark genome, suggesting that this receptor appeared early in vertebrate evolution . This high degree of conservation across species indicates that GPR153 likely serves fundamental biological functions that have been maintained throughout vertebrate evolution.

What is the expression pattern of GPR153 in tissues?

GPR153 exhibits a widespread expression pattern across both central nervous system and peripheral tissues. Quantitative real-time PCR studies have demonstrated that GPR153 is expressed throughout the central nervous system, with particularly high expression in specific brain regions . In situ hybridization studies on mouse brain have revealed notably high expression in the thalamus, cerebellum, and the arcuate nucleus . Analysis of single-cell data from human skin has confirmed the expression of GPR153 in both basal and differentiated (suprabasal) keratinocytes . Additionally, GPR153 has been found in the anterior pituitary of heifers, with some GPR153 colocalizing with gonadotropin-releasing hormone receptor (GnRHR) in the plasma membrane of bovine gonadotrophs, suggesting a potential role in reproductive processes . The expression level of GPR153 in the anterior pituitary appears to be dependent on reproductive stage .

How can recombinant GPR153 protein be properly handled and stored for research applications?

The optimal handling and storage of recombinant GPR153 requires specific conditions to maintain protein integrity and functionality. Recombinant human GPR153 protein is typically supplied as a lyophilized powder . Prior to opening, it is recommended that the vial be briefly centrifuged to bring all contents to the bottom . For reconstitution, the protein should be dissolved in deionized sterile water to achieve a concentration of 0.1-1.0 mg/mL .

For long-term storage, the addition of glycerol to a final concentration of 5-50% is recommended, with 50% being the standard concentration used by many suppliers . After reconstitution, the protein solution should be aliquoted to avoid repeated freeze-thaw cycles, which can degrade the protein . Working aliquots can be stored at 4°C for up to one week, while long-term storage requires temperatures of -20°C to -80°C . The storage buffer typically consists of a Tris/PBS-based solution with 6% trehalose at pH 8.0, which helps maintain protein stability .

What experimental approaches have been used to study GPR153 function?

Several experimental approaches have been utilized to investigate the functional role of GPR153:

• Antisense Oligodeoxynucleotide Knockdown: This technique has been employed to reduce GPR153 expression in vivo, allowing researchers to observe resulting phenotypes. Studies using this approach have shown that GPR153 knockdown causes a slight reduction in food intake, suggesting a potential role in appetite regulation .

• Behavioral Testing: The elevated plus maze test following GPR153 knockdown has revealed a significant reduction in the percentage of time spent in the center square, indicating a possible role for GPR153 in decision-making processes or anxiety-related behaviors .

• siRNA-Mediated Gene Silencing: In cultured keratinocytes, siRNA-mediated knockdown of GPR153 has been used to study its role in cellular processes. This approach demonstrated that GPR153 knockdown reduced keratinocyte proliferation but, unlike other GPCRs studied, did not affect differentiation .

• Transcriptomic Analysis: RNA sequencing following GPR153 knockdown has revealed that GPR153 regulates gene networks involved in both keratinocyte differentiation and cell cycle, though its knockdown was shown to downregulate both processes .

• 3D Skin-Organotypic Culture Models: Unlike other GPCRs tested (LTB4R, HCAR3, and GPR137), GPR153 overexpression did not appear to affect skin development in these models, suggesting specificity in its functional role .

What are the recommended techniques for analyzing GPR153 expression in tissue samples?

For comprehensive analysis of GPR153 expression in tissue samples, researchers have successfully employed multiple complementary techniques:

• Quantitative Real-Time PCR (qRT-PCR): This technique has been used to quantify GPR153 mRNA expression across various tissues, providing a broad overview of expression patterns. When conducting qRT-PCR for GPR153, appropriate reference genes such as cyclophilin or GAPDH should be used for normalization .

• In Situ Hybridization: This method provides detailed spatial information about GPR153 expression within tissues. It has been particularly valuable for mapping GPR153 expression in specific brain regions, revealing high expression in the thalamus, cerebellum, and arcuate nucleus .

• Single-Cell RNA Sequencing Analysis: Analysis of single-cell datasets has confirmed GPR153 expression in specific cell populations, such as basal and differentiated keratinocytes in human skin .

• Immunohistochemistry/Immunofluorescence: Although not explicitly mentioned in the provided search results, antibody-based detection methods would be appropriate for visualizing GPR153 protein localization within tissues.

• Co-localization Studies: These have been used to demonstrate that GPR153 colocalizes with other proteins of interest, such as GnRHR in bovine gonadotrophs, providing insights into potential functional interactions .

What is known about GPR153 signaling pathways and potential ligands?

GPR153 remains classified as an orphan receptor, meaning its endogenous ligand(s) have not yet been definitively identified . This presents a significant challenge and opportunity in GPCR research. As a member of the α-group of Rhodopsin family GPCRs, which includes many receptors for biogenic amines, it is possible that GPR153 might respond to similar types of signaling molecules, though this remains speculative .

The fact that GPR153 colocalizes with GnRHR in bovine gonadotrophs and its expression is dependent on reproductive stage suggests a potential role in reproductive hormone signaling pathways, though the precise mechanism requires further investigation . Methodological approaches to identify GPR153 ligands might include screening of compound libraries, proximity labeling techniques, or targeted metabolomic analyses focusing on biogenic amines given its phylogenetic placement.

How does GPR153 compare functionally with its evolutionary relative GPR162?

Phylogenetic and synteny analyses have established that GPR153 and GPR162 share a common ancestral gene that likely underwent a duplication event prior to the divergence of tetrapods and the teleost lineage . Despite this shared evolutionary origin, the functional relationship between these two receptors remains largely unexplored.

To investigate potential functional similarities or differences between GPR153 and GPR162, comparative studies examining expression patterns, knockdown phenotypes, and potential signaling pathways would be valuable. Methodological approaches could include:

• Comparative Expression Analysis: Simultaneous mapping of GPR153 and GPR162 expression patterns across tissues to identify areas of overlap or distinction.

• Parallel Knockdown/Knockout Studies: Comparing phenotypic effects of GPR153 and GPR162 depletion, both individually and in combination, to reveal potential functional redundancy or divergence.

• Chimeric Receptor Studies: Creating chimeric receptors containing domains from both GPR153 and GPR162 to identify regions responsible for specific functional properties.

• Co-immunoprecipitation Experiments: Investigating whether GPR153 and GPR162 physically interact or form heterodimers, which could suggest coordinated functions.

• Comparative Ligand Screening: Once candidate ligands are identified for either receptor, testing their activity on both GPR153 and GPR162 to determine specificity or cross-reactivity.

What role does GPR153 play in keratinocyte biology and skin homeostasis?

Research has demonstrated that GPR153 is expressed in both basal and differentiated (suprabasal) keratinocytes in human skin . Functional studies using siRNA-mediated knockdown have revealed that GPR153 regulates keratinocyte proliferation, as its depletion led to reduced proliferation in both primary human keratinocytes and immortalized N/TERT2G keratinocytes . This effect was observed in both full media (containing bovine pituitary extract) and defined media, indicating that the role of GPR153 in keratinocyte proliferation is not dependent on potential ligands present in pituitary extract .

Transcriptomic analysis following GPR153 knockdown showed downregulation of both keratinocyte differentiation and cell cycle networks . This differs from the effects observed with other GPCRs such as LTB4R, HCAR3, and GPR137, which upregulated differentiation while downregulating cell cycle processes . Unlike these other receptors, GPR153 knockdown did not upregulate genes associated with keratinocyte differentiation .

Furthermore, while overexpression of LTB4R, HCAR3, and GPR137 led to abnormal development in 3D skin-organotypic cultures, GPR153 overexpression did not affect skin development in these models . This suggests that GPR153 may have a more specific role in regulating keratinocyte proliferation without directly influencing differentiation processes.

Methodologically, investigations into the role of GPR153 in skin biology have employed:

• siRNA-mediated knockdown in keratinocyte cultures

• RNA sequencing to identify affected gene networks

• Western blot analysis for differentiation markers

• 3D skin-organotypic culture models

What are the implications of GPR153 expression in the thalamus, cerebellum, and arcuate nucleus?

The finding that GPR153 is highly expressed in the thalamus, cerebellum, and arcuate nucleus suggests potential roles in several key neurological functions :

• Thalamic Expression: The thalamus serves as a relay center for sensory and motor signals to the cerebral cortex and regulates consciousness, sleep, and alertness. GPR153's high expression in this region suggests it may contribute to these processes. Methodological approaches to investigate this could include electrophysiological recordings in thalamic slices following GPR153 manipulation, or behavioral testing of sensory processing and sleep patterns in GPR153 knockdown models.

• Cerebellar Expression: The cerebellum coordinates motor movements and is involved in certain cognitive functions. GPR153's expression here indicates a potential role in motor control or cerebellar cognitive functions. Research methodologies might include detailed motor testing in GPR153-deficient animals or cerebellar slice electrophysiology.

• Arcuate Nucleus Expression: The arcuate nucleus in the hypothalamus is critical for feeding behavior and energy homeostasis. This aligns with the observation that antisense oligodeoxynucleotide knockdown of GPR153 caused a slight reduction in food intake . Further investigation could employ methodologies such as hypothalamic slice recordings, metabolic chamber studies, or feeding behavior analysis following more targeted manipulation of GPR153 specifically in the arcuate nucleus.

• Decision-Making Processes: The finding that GPR153 knockdown led to reduced time spent in the center square of the elevated plus maze suggests a potential role in decision-making processes or anxiety-related behaviors . This could be further investigated using additional behavioral paradigms such as the open field test, light/dark box, or decision-making tasks.

What are the current challenges in studying orphan receptors like GPR153?

Studying orphan GPCRs like GPR153 presents several technical challenges:

• Unknown Endogenous Ligands: The lack of identified endogenous ligand(s) for GPR153 makes it difficult to study receptor activation and signaling under physiological conditions . This necessitates alternative approaches such as knockdown/knockout studies or overexpression of constitutively active mutants.

• Limited Pharmacological Tools: Without known ligands, there is a scarcity of specific agonists, antagonists, or allosteric modulators for GPR153, limiting the ability to manipulate receptor function acutely and specifically.

• Potential Constitutive Activity: Many orphan receptors exhibit constitutive (ligand-independent) activity, which can complicate the interpretation of experimental results, particularly in overexpression studies.

• Membrane Protein Expression Challenges: As a seven-transmembrane protein, GPR153 may present difficulties for structural studies due to challenges in expressing, purifying, and crystallizing membrane proteins while maintaining their native conformation.

To address these challenges, researchers might consider:

• Ligand Identification Strategies: Employing techniques such as reverse pharmacology, metabolomics-based approaches, or computational screening to identify potential ligands.

• CRISPR-Cas9 Genome Editing: Generating targeted knockouts or introducing reporter tags at endogenous loci to study receptor function and localization without overexpression artifacts.

• Single-Cell Analyses: Utilizing single-cell transcriptomics and proteomics to identify cell populations where GPR153 is highly expressed, potentially narrowing down physiological contexts for functional studies.

• Proximity Labeling Techniques: Employing methods such as BioID or APEX to identify proteins that physically interact with GPR153, potentially revealing components of its signaling pathways.

How can researchers design experiments to identify potential ligands for GPR153?

Identifying ligands for orphan receptors like GPR153 requires strategic experimental approaches:

• Phylogenetic-Based Screening: Since GPR153 belongs to the α-group of Rhodopsin family GPCRs, which includes many receptors for biogenic amines, a targeted screening approach focusing on structurally related biogenic amines and their derivatives would be a logical starting point .

• Cell-Based Functional Assays: Developing cell lines stably expressing GPR153 coupled to various readout systems (calcium flux, cAMP production, β-arrestin recruitment, etc.) to screen compound libraries for potential agonist or antagonist activity.

• Tissue-Specific Metabolomics: Given GPR153's high expression in specific brain regions and skin, analyzing the metabolome of these tissues could identify candidate endogenous ligands. Comparing metabolites between wild-type and GPR153-knockout tissues might reveal accumulation or depletion of potential ligands.

• Computational Approaches: Using molecular docking and virtual screening to predict compounds that might bind to the GPR153 binding pocket, based on homology models derived from structurally characterized GPCRs.

• Receptor Capture Technologies: Employing chemical biology approaches such as photoaffinity labeling or chemical crosslinking to capture endogenous ligands that interact with GPR153 in native tissues.

• Phenotypic Screening: Testing compounds for their ability to rescue or mimic phenotypes observed in GPR153 knockdown models, such as effects on keratinocyte proliferation or feeding behavior.

What future research directions might advance our understanding of GPR153 function?

Several promising research directions could significantly advance our understanding of GPR153:

• Comprehensive Tissue-Specific Knockout Studies: Generating conditional knockout models to eliminate GPR153 expression in specific tissues (brain regions, skin, anterior pituitary) to dissect its tissue-specific functions without developmental compensation.

• Structure Determination: Resolving the three-dimensional structure of GPR153 through cryo-electron microscopy or X-ray crystallography would provide invaluable insights into its potential ligand binding sites and activation mechanism.

• Signaling Pathway Characterization: Systematic investigation of G protein coupling preferences and downstream signaling pathways activated by GPR153, particularly in cellular contexts where it shows high expression.

• Disease Association Studies: Examining potential associations between GPR153 genetic variants and human diseases, particularly those affecting the central nervous system, skin, or reproductive function.

• Developmental Expression Analysis: Characterizing the temporal expression pattern of GPR153 during embryonic and postnatal development could reveal critical periods where it might play essential roles.

• Interactome Mapping: Identifying proteins that physically interact with GPR153 could reveal functional partners and provide clues about its physiological roles.

• Cross-Species Comparative Studies: Given the evolutionary conservation of GPR153, comparative studies across different species could highlight conserved functions and potentially simplify experimental approaches in model organisms.